B3B

Home/B3B

About B3B

This author has not yet filled in any details.
So far B3B has created 231 blog entries.

Spotlight: The Elizabeth Holmes and Theranos Saga

Since 2014, Big3Bio has shared the rise-and-fall coverage of Elizabeth Holmes and Theranos. With the most recent development of Holmes being indicted, we'll keep this post as a constantly-updated page on this developing story. UPDATED COVERAGE 6/21/18-6/28/18 Theranos founder Holmes loses bid to stay lawsuit amid criminal case - Reuters How Did Theranos' Holmes Fool [...]

June 18th, 2018|

Spotlight: Translational Biomarkers Event on May 14th

With so many patients relying on novel therapeutics for neurological disorders, the stakes are high when therapies reach the clinic. The best way to improve your chance for success is to design rigorous preclinical studies that include reproducible endpoints and robust biomarkers that predict clinical efficacy. Charles River hopes you join us as we further [...]

April 25th, 2018|

Spotlight: Interrogating the Immune System for Diagnosing Infection

Startup Inflammatix, founded in 2016 in Burlingame, California, takes a different approach to diagnosing infections. Rather than seeking the pathogen causing the infection, it uses a data-driven approach to evaluate the body’s immune system response to provide a diagnosis in as little as an hour. Big3Bio editor Marie Daghlian spoke with Dr. Timothy Sweeney, co-founder [...]

March 9th, 2018|

Event Recap: PMWC2018 — Artificial Intelligence Takes Center Stage

By Marie Daghlian The buzz around artificial intelligence, or AI, is palpable—similar to the buzz around CRISPR and immuno-oncology just a few years ago. VCs are throwing money at startups that are using AI. Proponents say it can solve the world’s problems, do what humans cannot. Others worry that it will run away from humans, [...]

February 5th, 2018|

Charles River’s 2nd Annual Viral Safety and Viral Clearance Summit

Charles River’s 2nd Annual Viral Safety and Viral Clearance Summit will be held October 10 – 11, 2017 at the San Mateo Marriott in San Mateo, CA. The 2-day summit, located in the Bay Area, unites industry professionals in an interactive setting to share updates and discuss trends in the realm of viral safety and [...]

August 3rd, 2017|

Charles River 23rd Annual Biotechnology-Derived Therapeutics Perspectives on Nonclinical Development Symposium

The Charles River 23rd Annual Biotechnology-Derived Therapeutics Perspectives on Nonclinical Development symposium will be held September 11-13, 2017 at Cape Rey Resort, Carlsbad, CA. This three-day symposium with five sessions has a jam-packed agenda with case study presentations from industry leaders from Bluebird, Janssen, Pfizer and Amgen in the nonclinical development of biotherapeutics. Don’t miss out on [...]

July 18th, 2017|
X